FOXO1 and Insulin resistance: It phosphorylates pro-apoptotic effectors (BAD, FOXO1) to enhance thyrocyte and orbital fibroblast survival, while mTORC1 hyperactivation accelerates metabolism, contributing to hypermetabolic phenotypes and insulin resistance.